Stock Groups

France’s Sanofi offers 1.5 billion euro bond linked to access to medicine -Breaking

by Mike Robinson

[ad_1]

© Reuters. FILEPHOTO: Sanofi logo in the headquarters of the company, during the annual results news conference held in Paris (France), February 4, 2022. REUTERS/Benoit Tessier

(Reuters). – French healthcare organization Sanofi (NASDAQ:) said it had priced a first sustainability-linked bond issue that will be indexed on access to medicines, and worth 1.5 billion euros ($1.7 billion).

The firm stated that the financing costs would depend on the attainment of concrete goals in the form of an increase in the number of patients receiving essential medicine over the next five-years.

Notes will be issued in two tranches each of 850 million and 650 millions euros.

Jean-Baptiste de Chatillon is chief financial officer of Sanofi. He stated, “We are making progress in our social, environmental and governance activities which are an essential part our strategy and embedded within our business.”

($1 = 0.8961 euros)

Disclaimer: Fusion MediaWe remind you that this site does not contain accurate or real-time data. CFDs are stocks, indexes or futures. The prices of Forex and CFDs are not supplied by exchanges. They are instead provided by market makers. As such, the prices might not reflect market values and could be incorrect. Fusion Media does not accept any liability for trade losses that you may incur due to the use of these data.

Fusion MediaFusion Media or any other person involved in the website will not be held responsible for any loss or damage resulting from reliance on this information, including charts, buy/sell signals, and data. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.

[ad_2]